Clinical Trial Detail

NCT ID NCT01630733
Title A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
Recruitment Unknown status
Gender both
Phase Phase III
Variant Requirements No
Sponsors OncoGenex Technologies
Indications

lung non-small cell carcinoma

Therapies

Docetaxel

Custirsen + Docetaxel

Age Groups: adult

No variant requirements are available.